Skip to main content
. Author manuscript; available in PMC: 2016 Mar 1.
Published in final edited form as: Stroke. 2015 Jan 15;46(3):827–834. doi: 10.1161/STROKEAHA.114.007145

Figure 1.

Figure 1

ABCA1−B/−B marginally increases lesion volume and decreases functional outcome after dMCAo. A. Schematic diagram shows the IBZ in the cortex and corpus callosum and the ischemic core in the cortex for immunostaining, and isolated brain tissue area from the ipsilateral brain or sham brain for Western blot and RT-qPCR; B: Lesion volume; C: Functional outcome.